ArticlePharmaceutics2024

The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial.

Victor Ciofoaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.